Akzo Nobel Inc.

Nashville, TN ManufacturingNAICS 325100

Self-funded health planPlan year 2025Renews January
2,036ParticipantsPrior year not comparable
$4.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#12 of 54Manufacturing in TNBy participants

Overview

Akzo Nobel Inc. sponsors a self-funded health plan that covered 2,036 participants in plan year 2025. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,036 · prior year 506
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Akzo Nobel Flexible Benefits Plan, plan 568 (2,036 participants); Akzo Nobel Retired Employees' Group Benefits Program, plan 595 (1,316 participants); Akzo Nobel Retired Hourly Group Benefits Program, plan 597 (180 participants); Akzo Nobel Hourly Employees Group Benefits Program, plan 574 (173 participants)
Broker compensation
$162K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Securian Life Insurance CompanyLife2,304$1.8M$127K
Reliance Standard Life Insurance CompanyLong-term disability2,437$433K$22K
Metropolitan Life Insurance CompanyVision5,987$246K$14K
ComPsych CorporationEmployee Assistance Program2,430$41K—
Ace American Insurance CompanyBusiness Travel Accident2,034$14K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$4.8M/ year

Estimated prescription spend: 2,036 participants × $2,371 national average per member. Usually higher once dependents are counted.

$126K–$309K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$37K–$92K
Lower-cost therapeutic alternatives$54K–$112K
Generic pricing vs. actual cost$23K–$70K
PBM contract terms$12K–$36K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Akzo Nobel Inc.
Sponsor EIN
56-1349341
Plan numbers
568, 595, 597, 574
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 56-1349341 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Akzonobel Retirement Savings Plan
Type
401(k) plan
Participants
4,611

About this data

Source: Akzo Nobel Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Akzo Nobel Inc..

Request a correction · Methodology